ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 256 filers reported holding NEOGENOMICS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q4 2020$1,388,000
-91.5%
25,779
-94.2%
0.00%
-92.3%
Q3 2020$16,262,000
-13.0%
440,832
-26.9%
0.03%
-23.5%
Q2 2020$18,692,000
+161.0%
603,347
+132.6%
0.03%
+70.0%
Q1 2020$7,161,000
+206.8%
259,347
+143.8%
0.02%
+300.0%
Q2 2019$2,334,000
-37.0%
106,395
-63.8%
0.01%
-50.0%
Q4 2018$3,706,000
+24.2%
293,890
+51.2%
0.01%
+42.9%
Q3 2018$2,984,000
+227.2%
194,365
+179.5%
0.01%
+250.0%
Q2 2018$912,000
-32.2%
69,543
-59.3%
0.00%
-60.0%
Q1 2017$1,345,000170,6740.01%
Other shareholders
NEOGENOMICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,291,019$22,47712.11%
Greenhouse Funds LLLP 2,930,014$51,011,5444.27%
First Light Asset Management, LLC 2,698,958$46,988,8594.23%
PERKINS CAPITAL MANAGEMENT INC 197,000$3,4303.23%
Altium Capital Management LP 240,000$4,178,4002.32%
FORMULA GROWTH LTD 280,690$4,886,8131.57%
BOULDER HILL CAPITAL MANAGEMENT LP 101,065$1,759,5421.42%
EMERALD MUTUAL FUND ADVISERS TRUST 1,374,783$23,934,9721.41%
EMERALD ADVISERS, LLC 1,669,324$29,062,9311.39%
Lisanti Capital Growth, LLC 528,235$9,196,5711.28%
View complete list of NEOGENOMICS INC shareholders